Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 2 Infection
Condition: Herpes Genitalis Interventions: Biological: HDIT101; Drug: Valaciclovir; Biological: HDIT101 placebo; Drug: Valaciclovir placebo Sponsor: Heidelberg ImmunoTherapeutics GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2019 Category: Research Source Type: clinical trials
Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 2 Infection
Condition: Herpes Genitalis Interventions: Biological: HDIT101; Drug: Valaciclovir; Biological: HDIT101 placebo; Drug: Valaciclovir placebo Sponsor: Heidelberg ImmunoTherapeutics GmbH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2019 Category: Research Source Type: clinical trials
Impact of Increased Immunoglobulin E to Anti-herpes Simplex Virus -1 Innate Immune Responses in Atopic Dermatitis Patients With Eczema Herpeticum
Conditions: Atopic Dermatitis With a History of Eczema Herpeticum; Atopic Dermatitis Without a History of Eczema Herpeticum; Health Controls Without Atopy Intervention: Biological: Xolair Sponsors: National Jewish Health; Genentech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2019 Category: Research Source Type: clinical trials